- Home
- AUDC vs PROC Comparison
AUDC vs PROC Comparison
Compare AUDC & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- PROC
- Stock Information
- Founded
- AUDC 1992
- PROC 1976
- Country
- AUDC Israel
- PROC Luxembourg
- Employees
- AUDC N/A
- PROC N/A
- Industry
- AUDC Telecommunications Equipment
- PROC Biotechnology: Pharmaceutical Preparations
- Sector
- AUDC Utilities
- PROC Health Care
- Exchange
- AUDC Nasdaq
- PROC Nasdaq
- Market Cap
- AUDC 266.8M
- PROC 203.1M
- IPO Year
- AUDC 1999
- PROC N/A
- Fundamental
- Price
- AUDC $9.69
- PROC $1.92
- Analyst Decision
- AUDC Buy
- PROC
- Analyst Count
- AUDC 2
- PROC 0
- Target Price
- AUDC $12.00
- PROC N/A
- AVG Volume (30 Days)
- AUDC 70.5K
- PROC 11.6K
- Earning Date
- AUDC 11-06-2024
- PROC 11-12-2024
- Dividend Yield
- AUDC 3.71%
- PROC N/A
- EPS Growth
- AUDC 3.49
- PROC N/A
- EPS
- AUDC 0.45
- PROC 0.52
- Revenue
- AUDC $245,529,000.00
- PROC $414,096,000.00
- Revenue This Year
- AUDC $1.88
- PROC $5.54
- Revenue Next Year
- AUDC $3.39
- PROC $8.54
- P/E Ratio
- AUDC $21.55
- PROC $3.72
- Revenue Growth
- AUDC N/A
- PROC N/A
- 52 Week Low
- AUDC $7.14
- PROC $1.68
- 52 Week High
- AUDC $14.45
- PROC $4.95
- Technical
- Relative Strength Index (RSI)
- AUDC 51.91
- PROC 43.98
- Support Level
- AUDC $9.42
- PROC $1.77
- Resistance Level
- AUDC $9.99
- PROC $2.06
- Average True Range (ATR)
- AUDC 0.21
- PROC 0.11
- MACD
- AUDC 0.06
- PROC -0.02
- Stochastic Oscillator
- AUDC 68.42
- PROC 25.86
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About PROC Procaps Group S.A.
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.